About Celsius Holdings, Inc. - Common Stock (CELH)
Celsius Holdings Inc is a health and wellness company that specializes in the development and marketing of fitness drinks and nutritional products. The company's primary focus is on creating functional beverages that are designed to boost metabolism, enhance energy levels, and promote overall well-being. Celsius offers a range of products, including energy drinks, powdered drink mixes, and protein bars, targeting fitness enthusiasts and consumers looking for healthier lifestyle options. With a strong emphasis on innovation and product quality, Celsius aims to differentiate itself in a competitive market while promoting an active and health-conscious lifestyle. Read More
Desantis increased his direct stake to 2.7 million shares as Celsius trades near $27.63, valuing his position at $75.38 million despite a -51% one-year return.
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH) and certain officers. The class action, filed in the United States District Court for the Southern District of Florida, and docketed under 26-cv-62465, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Celsius securities between February 21, 2025 and June 3, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Celsius Holdings, Inc. (“Celsius” or “the Company”) (NASDAQ: CELH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Celsius Holdings, Inc. (“Celsius” or the “Company”) (NasdaqCM: CELH), if they purchased the Company’s securities between February 21, 2025 and June 3, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Florida.
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...
The DJS Law Group reminds investors of a class action lawsuit against Celsius Holdings, Inc. (“Celsius” or “the Company”) (NASDAQ: CELH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Celsius Holdings, Inc. (“Celsius” or “the Company”) (NASDAQ: CELH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH) and certain officers. The class action, filed in the United States District Court for the Southern District of Florida, and docketed under 26-cv-62465, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Celsius securities between February 21, 2025 and June 3, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Celsius Holdings, Inc. (NASDAQ: CELH) securities between February 21, 2025 and June 3, 2026, inclusive (the "Class Period"). Celsius develops, processes, manufactures, markets, sells, and distributes products including energy drinks.
What Happened? Shares of energy drink company Celsius (NASDAQ:CELH) fell 5.9% in the afternoon session after Deutsche Bank analyst Steve Powers downgraded th...
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...
NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced the appointment of Caroline Levy to its Board of Directors as an independent director. Ms. Levy will also serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
Celsius’ second quarter was marked by a negative market reaction, as both revenue and non-GAAP profit fell short of Wall Street expectations. Management attr...
Celsius Holdings (NASDAQ: CELH) shareholders absorbed a sharp decline after the Company reported second-quarter revenue of $817.9 million against consensus estimates of more than $870 million, with core Celsius brand revenue down nearly 12%. If you lost money on CELH, you are encouraged to submit your information for a free case evaluation. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
